Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F de Groot

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Nature Reviews. Clinical Oncology|September 20, 2017
Chimeric antigen receptor T-cell therapy - assessment and management of toxicitiesSattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.
Neuro-Oncology|October 10, 2015
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II studyNicholas Butowski, Howard Colman, John F De Groot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium studyJohn F de Groot, Kathleen R Lamborn, Susan M Chang, et al.
Neuro-Oncology|January 5, 2020
Exclusion of patients with brain metastases from cancer clinical trialsRoshal R Patel, Vivek Verma, Austin B Miller, et al.
Neuro-Oncology|August 5, 2020
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photonsRadhe Mohan, Amy Y Liu, Paul D Brown, et al.
Cancer|October 26, 2018
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastomaStefania Maraka, Morris D Groves, Aaron G Mammoser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2018
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft ModelsPascal O Zinn, Sanjay K Singh, Aikaterini Kotrotsou, et al.
Neuro-Oncology|January 9, 2022
Liquid biopsy in gliomas: A RANO review and proposals for clinical applicationsRiccardo Soffietti, Chetan Bettegowda, Ingo K Mellinghoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
It is time to include patients with brain tumors in phase I trials in oncologyPatrick Y Wen, David Schiff, Timothy F Cloughesy, et al.
Neuro-Oncology Advances|January 11, 2021
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogramSherise D Ferguson, Tiffany R Hodges, Nazanin K Majd, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Nature Reviews. Clinical Oncology|September 20, 2017
Chimeric antigen receptor T-cell therapy - assessment and management of toxicitiesSattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.
Neuro-Oncology|October 10, 2015
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II studyNicholas Butowski, Howard Colman, John F De Groot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium studyJohn F de Groot, Kathleen R Lamborn, Susan M Chang, et al.
Neuro-Oncology|January 5, 2020
Exclusion of patients with brain metastases from cancer clinical trialsRoshal R Patel, Vivek Verma, Austin B Miller, et al.
Neuro-Oncology|August 5, 2020
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photonsRadhe Mohan, Amy Y Liu, Paul D Brown, et al.
Cancer|October 26, 2018
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastomaStefania Maraka, Morris D Groves, Aaron G Mammoser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2018
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft ModelsPascal O Zinn, Sanjay K Singh, Aikaterini Kotrotsou, et al.
Neuro-Oncology|January 9, 2022
Liquid biopsy in gliomas: A RANO review and proposals for clinical applicationsRiccardo Soffietti, Chetan Bettegowda, Ingo K Mellinghoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
It is time to include patients with brain tumors in phase I trials in oncologyPatrick Y Wen, David Schiff, Timothy F Cloughesy, et al.
Neuro-Oncology Advances|January 11, 2021
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogramSherise D Ferguson, Tiffany R Hodges, Nazanin K Majd, et al.
Pageof 13